US5395760A
(en)
*
|
1989-09-05 |
1995-03-07 |
Immunex Corporation |
DNA encoding tumor necrosis factor-α and -β receptors
|
NZ235148A
(en)
|
1989-09-05 |
1991-12-23 |
Immunex Corp |
Tumour necrosis factor receptor protein and dna sequences
|
US6541610B1
(en)
|
1989-09-05 |
2003-04-01 |
Immunex Corporation |
Fusion proteins comprising tumor necrosis factor receptor
|
EP1132471A3
(de)
|
1989-09-12 |
2001-11-28 |
F. Hoffmann-La Roche Ag |
TNF-bindende Proteine
|
EP0533006A1
(en)
*
|
1991-09-18 |
1993-03-24 |
F.Hoffmann-La Roche & Co. Aktiengesellschaft |
Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
|
DE4322330A1
(de)
|
1992-08-31 |
1994-03-03 |
Behringwerke Ag |
Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
|
AU4382193A
(en)
*
|
1992-05-19 |
1993-12-13 |
Xoma Corporation |
BPI-immunoglobulin fusion proteins
|
US6274348B1
(en)
|
1992-05-19 |
2001-08-14 |
Xoma Corporation |
Methods for the preparation of positively charged proteins
|
DE4228839A1
(de)
*
|
1992-08-29 |
1994-03-03 |
Behringwerke Ag |
Verfahren zum Nachweis und zur Bestimmung von Mediatoren
|
CA2161971A1
(en)
*
|
1993-04-30 |
1994-11-10 |
Randal W. Scott |
Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
|
DE4407386B4
(de)
*
|
1994-03-05 |
2009-01-15 |
Dade Behring Marburg Gmbh |
Verfahren zur Reaktivierung von gereinigten Membranproteinen durch Einfrieren
|
WO1995030154A1
(en)
*
|
1994-04-28 |
1995-11-09 |
Dade International Inc. |
Calibrator for prothrombin time (pt) assays
|
CN1117155C
(zh)
*
|
1994-07-29 |
2003-08-06 |
史密丝克莱恩比彻姆有限公司 |
新型化合物
|
US6410008B1
(en)
|
1994-12-12 |
2002-06-25 |
Beth Israel Hospital Association |
Chimeric IL-10 proteins and uses thereof
|
CA2205572A1
(en)
|
1994-12-12 |
1996-06-20 |
Beth Israel Hospital Association |
Chimeric cytokines and uses thereof
|
DE69627820T2
(de)
*
|
1995-01-17 |
2004-04-08 |
The Brigham And Women's Hospital Inc., Boston |
Rezeptorspezifischer transepithelialer transport von immunogenen
|
US6485726B1
(en)
|
1995-01-17 |
2002-11-26 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
DE19538716A1
(de)
*
|
1995-10-18 |
1997-04-24 |
Behringwerke Ag |
Verfahren zur Quantifizierung von aktiviertem Gerinnungsfaktor VII (FVIIa)
|
US7427492B1
(en)
|
1995-06-05 |
2008-09-23 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human tumor necrosis factor receptor-like2
|
US7429646B1
(en)
|
1995-06-05 |
2008-09-30 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor-like 2
|
AU6163196A
(en)
*
|
1995-06-07 |
1996-12-30 |
Smithkline Beecham Corporation |
Method for obtaining receptor agonist antibodies
|
GB9511935D0
(en)
*
|
1995-06-13 |
1995-08-09 |
Smithkline Beecham Plc |
Novel compound
|
DE19538715A1
(de)
*
|
1995-10-18 |
1997-04-30 |
Behringwerke Ag |
Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
|
US20030040467A1
(en)
|
1998-06-15 |
2003-02-27 |
Mary Ann Pelleymounter |
Ig/ob fusions and uses thereof.
|
US6936439B2
(en)
|
1995-11-22 |
2005-08-30 |
Amgen Inc. |
OB fusion protein compositions and methods
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US6635743B1
(en)
|
1996-03-22 |
2003-10-21 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule II and methods of use
|
US7964190B2
(en)
|
1996-03-22 |
2011-06-21 |
Human Genome Sciences, Inc. |
Methods and compositions for decreasing T-cell activity
|
US5866341A
(en)
*
|
1996-04-03 |
1999-02-02 |
Chugai Pharmaceutical Co., Ltd. |
Compositions and methods for screening drug libraries
|
ES2316153T3
(es)
|
1996-08-16 |
2009-04-01 |
Human Genome Sciences, Inc. |
Endoquina alfa humana.
|
PT963377E
(pt)
|
1996-08-30 |
2009-05-11 |
Human Genome Sciences Inc |
Interleucina 19
|
KR20050004269A
(ko)
|
1996-10-25 |
2005-01-12 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
뉴트로킨 알파
|
JP4771563B2
(ja)
|
1996-12-06 |
2011-09-14 |
アムジエン・インコーポレーテツド |
Il−1媒介疾患を処置するためにil−1インヒビターを使用する組合せ療法
|
US6455040B1
(en)
|
1997-01-14 |
2002-09-24 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptor 5
|
PT1012274E
(pt)
|
1997-01-28 |
2007-08-14 |
Craig A Rosen |
Receptor 4 contendo um domínio de morte (dm4; receptor de morte 4), membro da super-família do ftn e ligação a liart (ap02)
|
US7452538B2
(en)
|
1997-01-28 |
2008-11-18 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US8329179B2
(en)
|
1997-01-28 |
2012-12-11 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
US6433147B1
(en)
|
1997-01-28 |
2002-08-13 |
Human Genome Sciences, Inc. |
Death domain containing receptor-4
|
US6872568B1
(en)
|
1997-03-17 |
2005-03-29 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5 antibodies
|
CA2291221A1
(en)
|
1997-05-30 |
1998-12-03 |
Human Genome Sciences, Inc. |
32 human secreted proteins
|
US6242570B1
(en)
|
1997-07-10 |
2001-06-05 |
Beth Israel Deaconess Medical Center |
Production and use of recombinant protein multimers with increased biological activity
|
AU8182298A
(en)
*
|
1997-07-10 |
1999-02-08 |
Beth Israel Deaconess Medical Center |
Recombinant erythropoietin / immunoglobulin fusion proteins
|
US6165476A
(en)
*
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
US6187564B1
(en)
|
1997-07-10 |
2001-02-13 |
Beth Israel Deaconess Medical Center |
DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
|
JP2002017353A
(ja)
*
|
1997-12-19 |
2002-01-22 |
Japan Tobacco Inc |
変性ldlの定量方法
|
JP4409763B2
(ja)
|
1998-01-23 |
2010-02-03 |
イミュネックス・コーポレーション |
Acpldnaおよびポリペプチド
|
EP1093457B8
(en)
|
1998-03-19 |
2011-02-02 |
Human Genome Sciences, Inc. |
Cytokine receptor common gamma chain like
|
US7083949B2
(en)
|
1998-09-25 |
2006-08-01 |
Regeneron Pharmaceuticals, Inc. |
Receptor based antagonists and methods of making and using
|
US6927044B2
(en)
|
1998-09-25 |
2005-08-09 |
Regeneron Pharmaceuticals, Inc. |
IL-1 receptor based cytokine traps
|
US6472179B2
(en)
*
|
1998-09-25 |
2002-10-29 |
Regeneron Pharmaceuticals, Inc. |
Receptor based antagonists and methods of making and using
|
JP4486256B2
(ja)
|
1998-10-22 |
2010-06-23 |
ザ・ジェネラル・ホスピタル・コーポレイション |
副甲状腺ホルモン(PTH)および副甲状腺ホルモン関連ペプチド(PTHrP)の生物活性ペプチドおよびペプチド誘導体
|
WO2000040698A1
(en)
|
1998-12-31 |
2000-07-13 |
The General Hospital Corporation |
Pth receptor and screening assay utilizing the same
|
US6656728B1
(en)
|
1999-02-08 |
2003-12-02 |
Chiron Corporation |
Fibroblast growth factor receptor-immunoglobulin fusion
|
WO2000050620A2
(en)
|
1999-02-26 |
2000-08-31 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
EP1177285A1
(en)
*
|
1999-05-07 |
2002-02-06 |
Genentech, Inc. |
Chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
|
US6362324B1
(en)
*
|
1999-06-30 |
2002-03-26 |
Millennium Pharmaceuticals, Inc. |
17867 a novel human aminopeptidase
|
US6369210B1
(en)
*
|
1999-06-30 |
2002-04-09 |
Millennium Pharmaceuticals, Inc. |
22012, human carboxypeptidase
|
AU7734800A
(en)
|
1999-09-29 |
2001-04-30 |
General Hospital Corporation, The |
Polypeptide derivatives of parathyroid hormone (pth)
|
US6808902B1
(en)
|
1999-11-12 |
2004-10-26 |
Amgen Inc. |
Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
|
US6248353B1
(en)
|
1999-12-10 |
2001-06-19 |
Dade Behring Inc. |
Reconstitution of purified membrane proteins into preformed liposomes
|
CA2401993A1
(en)
|
2000-03-02 |
2001-09-07 |
Abgenix, Inc. |
Human monoclonal antibodies against oxidized ldl receptor and pharmaceutical uses thereof
|
AU2001259758A1
(en)
|
2000-05-12 |
2001-11-26 |
Immunex Corporation |
Interleukin-1 inhibitors in the treatment of diseases
|
DK2990420T3
(en)
|
2000-05-26 |
2017-04-03 |
Immunex Corp |
USE OF INTERLEUKIN-4 RECEPTOR ANTIBODIES AND COMPOSITIONS THEREOF
|
IL154596A0
(en)
|
2000-08-25 |
2003-09-17 |
Basf Plant Science Gmbh |
Plant polynucleotides encoding novel prenyl proteases
|
US6989247B2
(en)
|
2000-11-28 |
2006-01-24 |
Celltech R & D, Inc. |
Compositions and methods for diagnosing or treating psoriasis
|
EP1683865A3
(en)
|
2001-02-02 |
2006-10-25 |
Eli Lilly & Company |
Mammalian proteins and in particular CD200
|
DK1385864T3
(da)
|
2001-04-13 |
2010-08-16 |
Human Genome Sciences Inc |
Anti-VEGF-2-antistoffer
|
DK1572874T3
(da)
|
2001-05-25 |
2013-12-16 |
Human Genome Sciences Inc |
Antistoffer, der immunospecifikt binder til TRAIL receptorer
|
US7361341B2
(en)
|
2001-05-25 |
2008-04-22 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
US7348003B2
(en)
|
2001-05-25 |
2008-03-25 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
|
ATE464068T1
(de)
|
2001-06-26 |
2010-04-15 |
Amgen Fremont Inc |
Antikörper gegen opgl
|
WO2003009804A2
(en)
|
2001-07-23 |
2003-02-06 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormone (pth) analogs
|
KR100453877B1
(ko)
*
|
2001-07-26 |
2004-10-20 |
메덱스젠 주식회사 |
연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 TNFR/Fc 융합 단백질, 상기 단백질을 코딩하는 DNA, 상기 DNA를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
|
AU2003254016A1
(en)
|
2002-07-19 |
2004-02-09 |
Catholic Healthcare West |
Methods and compositions relating to chimeric nicotinic receptor subunits
|
WO2004035618A2
(en)
|
2002-10-15 |
2004-04-29 |
Intercell Ag |
Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
|
DE602004022923D1
(de)
|
2003-03-04 |
2009-10-15 |
Intercell Ag |
Streptococcus pyogenes antigene
|
US7795220B2
(en)
|
2003-03-19 |
2010-09-14 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormones with alpha-helix stabilizers
|
CA2522238A1
(en)
|
2003-04-15 |
2004-10-28 |
Intercell Ag |
S. pneumoniae antigens
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
EP2298347B1
(en)
|
2003-05-06 |
2015-09-30 |
Biogen Hemophilia Inc. |
Clotting factor chimeric proteins for treatment of a hemostatic disorder
|
AU2012203896B2
(en)
*
|
2003-05-06 |
2014-09-25 |
Bioverativ Therapeutics Inc. |
Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia
|
JP2007535894A
(ja)
|
2003-05-07 |
2007-12-13 |
インターツェル・アクチェンゲゼルシャフト |
ストレプトコッカス・アガラクティエ抗原i+ii
|
EP2327720A1
(en)
|
2003-05-30 |
2011-06-01 |
Intercell AG |
Enterococcus antigens
|
EP1653985A4
(en)
|
2003-07-17 |
2009-08-05 |
Gen Hospital Corp |
CONSTRAINTS CONTAINING CONTAINING HORMONE PARATHYROID (PTH) ANALOGUES
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
CN103212084B
(zh)
|
2003-11-13 |
2018-07-13 |
韩美科学株式会社 |
含有免疫球蛋白fc区作为载体的药物组合物
|
CA2563675C
(en)
|
2004-04-22 |
2012-08-28 |
Talecris Biotherapeutics, Inc. |
Recombinantly modified plasmin
|
EP1598428A1
(en)
|
2004-05-18 |
2005-11-23 |
Georg Dewald |
Methods and kits to detect Hereditary angioedema type III
|
US20070264277A1
(en)
|
2004-07-22 |
2007-11-15 |
Dirk Behrens |
Compositions and Methods of Use for Mgd-Csf in Disease Treatment
|
US7745446B2
(en)
|
2004-09-06 |
2010-06-29 |
Bayer Schering Pharma Aktiengesellschaft |
Pyrazolo[1,5-c]pyrimidines
|
US7589179B2
(en)
*
|
2004-12-09 |
2009-09-15 |
Merck Patent Gmbh |
IL-7 variants with reduced immunogenicity
|
WO2006110589A2
(en)
|
2005-04-07 |
2006-10-19 |
The Cleveland Clinic Foundation |
Gammaretrovirus associated with cancer
|
KR100754667B1
(ko)
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Fc 단편 및이를 포함하는 약제학적 조성물
|
AU2006280587B2
(en)
|
2005-08-16 |
2011-02-24 |
Hanmi Science Co., Ltd. |
A method for the mass production of immunoglobulin Fc region deleted initial methionine residues
|
WO2007030820A2
(en)
|
2005-09-09 |
2007-03-15 |
The Johns Hopkins University |
Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists
|
CA2626082C
(en)
|
2005-10-13 |
2017-04-11 |
Human Genome Sciences, Inc. |
Methods and compositions for use in treatment of patients with autoantibody positive disease
|
WO2007056352A2
(en)
|
2005-11-07 |
2007-05-18 |
The Scripps Research Institute |
Compositions and methods for controlling tissue factor signaling specificity
|
EP1785434A1
(en)
|
2005-11-11 |
2007-05-16 |
Ludwig-Maximilians-Universität München |
Targeting and tracing of antigens in living cells
|
EP1973946B1
(en)
|
2006-01-20 |
2015-03-25 |
Cell Signaling Technology, Inc. |
Translocation and mutant ros kinase in human non-small cell lung carcinoma
|
US7625564B2
(en)
|
2006-01-27 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
|
DK2029799T3
(da)
|
2006-04-20 |
2012-12-10 |
Becton Dickinson Co |
Termostabile proteiner og fremgangsmåder til fremstilling og anvendelse heraf
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
JP2009545320A
(ja)
|
2006-08-04 |
2009-12-24 |
ザ ジェネラル ホスピタル コーポレイション |
副甲状腺ホルモン(pth)のポリペプチド誘導体
|
AU2007295927A1
(en)
|
2006-09-15 |
2008-03-20 |
Intercell Ag |
Borrelia antigens
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
KR100888022B1
(ko)
|
2006-12-21 |
2009-03-09 |
재단법인 목암생명공학연구소 |
면역글로불린 Fc와 인간 아포리포단백질(a)크링글절편의 융합단백질 LK8Fc
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
US8236326B2
(en)
|
2007-05-02 |
2012-08-07 |
Intercell Ag |
Klebsiella antigens
|
EP2167530A2
(en)
|
2007-06-18 |
2010-03-31 |
Intercell AG |
Chlamydia antigens
|
BRPI0814465B1
(pt)
|
2007-07-26 |
2021-11-23 |
Novagen Holding Corporation |
Proteína de fusão, dímero, método para produzir uma proteína de fusão, linhagem de célula, usos de uma proteína de fusão e de uma composição farmacêutica e composição farmacêutica
|
MX353986B
(es)
|
2007-08-01 |
2017-11-06 |
Massachusetts Gen Hospital |
Metodos de analisis y seleccion usando receptores acoplados a proteina g y composiciones relacionadas.
|
EP2199391B1
(en)
|
2007-09-27 |
2015-11-11 |
Japan Tobacco, Inc. |
Factor involved in latent infection with herpesvirus, and use thereof
|
AU2008314567B2
(en)
|
2007-10-18 |
2014-11-20 |
Cell Signaling Technology, Inc. |
Translocation and mutant ROS kinase in human non-small cell lung carcinoma
|
CA2711394A1
(en)
|
2008-01-11 |
2009-07-16 |
Synovex Corporation |
Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders
|
EP2274437B1
(en)
|
2008-04-10 |
2015-12-23 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting egfr mutations in cancer
|
KR20110017903A
(ko)
|
2008-06-04 |
2011-02-22 |
테일크리스 바이오쎄러퓨틱스 아이엔씨. |
플라스민의 제조를 위한 조성물, 방법 및 키트
|
JP5563572B2
(ja)
|
2008-07-23 |
2014-07-30 |
ハンミ サイエンス カンパニー リミテッド |
三末端官能基を有する非ペプチド性重合体を用いた生理活性ポリペプチド薬物結合体
|
EP3266795A1
(en)
|
2009-02-12 |
2018-01-10 |
Cell Signaling Technology, Inc. |
Method for detecting a fig-ros fusion polynucleotide
|
US8617574B2
(en)
|
2009-02-13 |
2013-12-31 |
Valneva Austria Gmbh |
Nontypable Haemophilus influenzae antigens
|
PL2403865T3
(pl)
|
2009-03-03 |
2016-01-29 |
Grifols Therapeutics Inc |
Sposoby wytwarzania plazminogenu
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
CN102821787B
(zh)
|
2010-01-15 |
2015-07-29 |
麒麟-安姆根有限公司 |
抗体制剂和治疗方案
|
US8883739B2
(en)
|
2010-01-19 |
2014-11-11 |
The Trustees Of Columbia University In The City Of New York |
Osteocalcin as a treatment for male reproductive disorders
|
WO2013033680A1
(en)
|
2011-09-02 |
2013-03-07 |
Lifenet Health |
Bmp peptides & methods of use
|
KR20190000385A
(ko)
|
2010-05-04 |
2019-01-02 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
섬유증의 검출 및 치료
|
MX358161B
(es)
|
2010-05-13 |
2018-08-06 |
The General Hospital Corp Star |
Analogos de hormona paratiroidea y usos para los mismos.
|
SI2593128T1
(en)
|
2010-07-15 |
2018-08-31 |
Adheron Therapeutics, Inc. |
Humanized antibodies targeting the EC1 Kaderina-11 domain and associated compositions and procedures
|
WO2013016220A1
(en)
|
2011-07-22 |
2013-01-31 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
KR101937733B1
(ko)
|
2012-05-24 |
2019-01-11 |
마운트게이트 그룹 리미티드 |
광견병 감염의 방지 및 치료에 관한 조성물 및 방법
|
EP2685260A1
(en)
|
2012-07-09 |
2014-01-15 |
Ludwig-Maximilians-Universität München |
Direct and quantitative detection of targets in living cells
|
KR101609840B1
(ko)
*
|
2012-07-12 |
2016-04-07 |
한국생명공학연구원 |
항체의 Fc 부위 결합 펩타이드를 이용한 항체 정제용 흡착 칼럼
|
PL2895188T3
(pl)
|
2012-09-11 |
2018-06-29 |
Coherus Biosciences, Inc. |
Prawidłowo pofałdowany etanercept o wysokiej czystości i doskonałej wydajności
|
KR102073748B1
(ko)
|
2013-01-31 |
2020-02-05 |
한미약품 주식회사 |
재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
|
WO2014152497A2
(en)
|
2013-03-15 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Osteocalcin as a treatment for cognitive disorders
|
AR096891A1
(es)
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo
|
WO2015153144A1
(en)
|
2014-03-31 |
2015-10-08 |
Kirin-Amgen, Inc. |
Methods of treating nail and scalp psoriasis
|
US20170246259A1
(en)
|
2014-09-10 |
2017-08-31 |
Georgetown University |
Compositions and Methods of Using Interleukin-4 Induced Gene 1 (IL-4I1)
|
EP3226889A4
(en)
|
2014-11-19 |
2018-11-21 |
The Trustees of Columbia University in the City of New York |
Osteocalcin as a treatment for frailty associated with aging
|
EP3268042A4
(en)
|
2015-03-13 |
2018-08-01 |
Samsung Bioepis Co., Ltd. |
Anti-tnf-alpha polypeptide composition and use thereof
|
WO2019094595A2
(en)
|
2017-11-09 |
2019-05-16 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
US20210277118A1
(en)
|
2018-06-21 |
2021-09-09 |
Daiichi Sankyo Company, Limited |
Compositions including cd3 antigen binding fragments and uses thereof
|
WO2020053808A1
(en)
|
2018-09-12 |
2020-03-19 |
Georg Dewald |
Method of diagnosing vasoregulatory disorders
|
EP4277665A1
(en)
|
2021-01-13 |
2023-11-22 |
Memorial Sloan Kettering Cancer Center |
Anti-dll3 antibody-drug conjugate
|
KR20230146521A
(ko)
|
2021-01-13 |
2023-10-19 |
메모리얼 슬로안 케터링 캔서 센터 |
항체-피롤로벤조디아제핀 유도체 접합체
|